AbbVie (ABBV) Tops Q4 EPS by 3c, Confirms Guidance

AbbVie (NYSE: ABBV) reported Q4 EPS of $0.89, $0.03 better than the analyst estimate of $0.86. Revenue for the quarter came in at $5.45 billion versus the consensus estimate of $5.34 billion.AbbVie reaffirmed FY2015 guidance.

Confirming Full-Year 2015 Outlook

AbbVie is confirming its adjusted diluted earnings-per-share guidance for the full-year 2015 of $4.25 to $4.45, which reflects industry-leading growth versus the prior year. The company's 2015 adjusted diluted earnings-per-share guidance excludes $0.34 per share of intangible asset amortization expense and other specified items. Including these items, AbbVie's diluted earnings-per-share guidance is $3.91 to $4.11 on a GAAP basis.

For earnings history and earnings-related data on AbbVie (ABBV) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo
• Oppenheimer turns cautious on major U.S. banks, favors alternative asset managers